Beyond Air
Formerly Advanced Inhalation Therapies
Treatment Solutions for Respiratory Diseases
Startup Public Health Tech & Life Sciences Est. 2011
🌐 WebsiteLinkedInTwitterCareers
Total Raised
$69.54M
Public
Last Round
$20.6M
7 rounds
Investors
2
2 public
Team
4
51-200 employees
Confidence
90/100
News
126
articles
Patents
1
About
Beyond Air is harnessing nitric oxide's pulmonary, antimicrobial, anti-inflammatory, and immunomodulatory mechanisms of action to deliver global access to more treatment options from hospital to home. Its revolutionary LungFit technology platform generates nitric oxide (NO) on-demand from ambient air and safely delivers it to patients to treat a variety of lung diseases. The LungFit PH is the first and only FDA approved system with patented Ionizer technology that generates nitric oxide using room air, enabling the delivery of unlimited, on-demand nitric oxide regardless of dose or flow.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target Customer
Healthcare & Life SciencesHealthcareProvidersPatientsLife SciencesPharmaceuticals
Business Model
B2B
Tags
medical-deviceschronic-diseaserespiratoryasthmainfectionpharmaceuticalspulmonaryinhalationchronic-patients
Funding & Events
Sep 2024
PIPE $20.6M
Mar 2024
PIPE $16M
Undisclosed Investor(s)
Jun 2023
Debt Financing $17.5M
Avenue Capital Group (Lead)
Feb 2018
Exit Undisclosed
Feb 2017
Exit Undisclosed
Dec 2012
Seed $1.3M
Undisclosed Investor(s)
Aug 2015
Exit Undisclosed
News (126)
Oct 23, 2025 · finance.yahoo.com
growth-positive
Beyond Air Schedules Second Fiscal Quarter 2026 Financial Results Conference Call and Webcast
FDA approvedPartnersProduct Stage
Sep 22, 2025 · finance.yahoo.com
growth-positive
Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
Product StagePartnersFDA approved/pending approval
Sep 8, 2025 · finance.yahoo.com
growth-negative
BC-Most Active Stocks
Sep 8, 2025 · finance.yahoo.com
growth-positive
Top Midday Gainers
PIPE
Sep 8, 2025 · finance.yahoo.com
growth-positive
Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds
PIPE/PO
Sep 8, 2025 · finance.yahoo.com
growth-positive
NeuroNOS Granted FDA Orphan Drug Designation for Glioblastoma, the Most Common and Deadliest Primary Malignant Brain Cancer in Adults
Product Stage
Sep 3, 2025 · finance.yahoo.com
growth-positive
Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
FDA approved/pending approvalPartners
Aug 27, 2025 · finance.yahoo.com
growth-positive
Astera Labs Among 3 Leading Growth Companies With Strong Insider Ownership
Partners
Aug 20, 2025 · finance.yahoo.com
growth-positive
Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan
PartnersProduct Stage
Aug 13, 2025 · finance.yahoo.com
growth-positive
Beyond Air Inc (XAIR) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Expansion ...
CustomersPartnersProduct Stage
Aug 12, 2025 · finance.yahoo.com
growth-positive
Beyond Air® Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update
CustomersPartnersProduct Stage
Aug 12, 2025 · finance.yahoo.com
growth-negative
Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates
Aug 7, 2025 · finance.yahoo.com
growth-positive
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Beats Revenue Estimates
Jul 25, 2025 · finance.yahoo.com
growth-positive
Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast
Product StagePartnersFDA approved/pending approval
Jul 22, 2025 · finance.yahoo.com
growth-positive
Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.
Partners
Jun 26, 2025 · finance.yahoo.com
growth-positive
Here's Why Beyond Air (XAIR) Could be Great Choice for a Bottom Fisher
Jun 19, 2025 · finance.yahoo.com
growth-positive
Beyond Air Full Year 2025 Earnings: EPS Beats Expectations, Revenues Lag
Jun 18, 2025 · finance.yahoo.com
growth-positive
Beyond Air Inc (XAIR) (Q4 2025) Earnings Call Highlights: Revenue Soars Amidst Strategic Global ...
CustomersPartnersFDA approved/pending approval
Jun 17, 2025 · finance.yahoo.com
growth-positive
Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
CustomersPartnersManagement ChangesProduct Stage
Jun 16, 2025 · finance.yahoo.com
growth-positive
Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH
Product StageFDA approved/pending approval
+ 106 more articles
Details
Product Stage
Clinical Trial
Employees
51-200
Exact Count
67
District
Center District
Founded
2011
Registrar
514609387
Crunchbase
ait
Locations
Eli Horovitz Street 12, Rehovot, Israel
825 East Gate Boulevard, Garden City, NY, United States
Links
Website
www.beyondair.net/
LinkedIn
Profile
Twitter
Profile
Careers
Open positions
Admin
Last Update
Oct 23, 2025
Verified by
Yanina Wainscheinker
Missing
markets, not claimed
Team (4)
Amir Avniel
President, Chief Operating Officer & Co-founder
Founder
Steve Lisi
CEO & Chairman of the Board
Yossef Av-Gay
Co-founder
Founder
Ronit Hadass
Operation & HR manager
Internal
Created by
Raz Zohar (raz@platterz.ca)
Created
2014-09-03T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)
Status
Public on NASDAQ on Aug, 2015<br>
Finder · Beyond Air · 2026